Sheel Biotech Ltd (SHEEL) — shareholding pattern, promoter holding, financials and share price
About Sheel Biotech Ltd (SHEEL)
Sheel Biotech Ltd operates in the Industrial Products industry, within the Capital Goods sector. It trades on the NSE as SHEEL and on the BSE under scrip code 92363. Its ISIN is INE0YJV01017.
Incorporated in November 199, Sheel Biotech Limited specializes in biotechnology, floriculture, greenhouses, and organic projects. [1]
Listed peers in Industrial Products: International Combustion (India) Ltd, Chemtech Industrial Valves Ltd, ATV Projects India Ltd, Rapicut Carbides Ltd, Barflex Polyfilms Ltd.
Valuation & Returns
10 Jul 2026At ₹69 a share on 10 Jul 2026, Sheel Biotech Ltd (SHEEL) was valued at a price-to-earnings ratio of 11.94x against an industry P/E of 48.01x and a price-to-book of 1.11x on a book value of ₹62.4 per share. Solomo computes return on equity of 9.26% and return on capital employed of 11.72% from filed results.
- P/E
- 11.94x
- Industry P/E
- 48.01x
- P/B
- 1.11x
- EPS (TTM)
- ₹7.21
- Book value / share
- ₹62.4
- ROE
- 9.26%
- ROCE
- 11.72%
- ROA
- 8.07%
- Debt / equity
- 0.07x
- Dividend yield
- 0%
- EBITDA margin
- 15.44%
- 52-week range
- ₹37.8 – ₹95.55
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Sheel Biotech Ltd (SHEEL) reported revenue of ₹110 crore, net profit of ₹12 crore and earnings per share of ₹5.78. That compares with revenue of ₹110 crore and net profit of ₹11 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Sep 2025, revenue was ₹22 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 84 | 89 | 103 | 110 | 110 |
| Net profit (₹ cr) | 5 | 5 | 10 | 11 | 12 |
| EPS (₹) | 10.88 | 12.26 | 25.27 | 7.12 | 5.78 |
| Measure | 3Y | 1Y |
|---|---|---|
| Sales growth | 12.88% | 7.11% |
| Profit growth | 33.11% | 1.62% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 72.3% of Sheel Biotech Ltd (SHEEL). Market capitalisation was ₹140 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2026.
Largest disclosed public shareholders in Mar 2026: AARTH AIF GROWTH FUND 3.2%, BHARAT VENTURE OPPORTUNITIES FUND 3.12%, SANSHI FUND-I 1.97%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 72.3% | - | - | - | - |